scorecardresearch
Dr. Reddy's Laboratories

Dr. Reddy's Laboratories

 

More Stories on Dr. Reddy's Laboratories
Talks between the Centre and the Hyderabad-based drug major are on. Dr Reddy's is the sole licensing partner for Sputnik V in India

Sputnik V in India: Dr Reddy's to begin supply of COVID-19 vaccine imported from Russia in May

Apr 14, 2021

Drug major Dr Reddy's Laboratories is also going to tap domestically sourced jabs as their production speeds up in India

Netizens bash Modi govt on petrol prices; Job vacancies rise in Jan

Feb 16, 2021

With no relief in sight from incessant rise in petrol and diesel prices, people turned to Twitter to vent their frustrations on the matter; The central government is set to notify the rules under new labour codes, which will have an impact on employees' cost to company (CTC) as well as employers' wage bills; Vaccination drive against COVID-19 and improving economic indicators have enthused employers to recruit. Watch this and more on News Blast.

Also Read: Amazon to manufacture Fire TV Stick in India from this year

Pfizer moves US court against Indian drug makers Aurobindo Pharma Ltd and Dr Reddy's Laboratories over its cancer drug's patent infringement

Pfizer drags Aurobindo Pharma, Dr Reddy's to US court over cancer drug

Nov 17, 2020

Pfizer filed a possible patent infringement petition against both companies in the United States District Court for the District of Delaware and two counts last week

Now a bicycle for Rs 3.7 lakh; Dr Reddy's to provide Russian vaccine in India

Sep 17, 2020

Premium bicycle maker Scott Sports India on Wednesday introduced a full suspension cross country bicycle Spark RC 900 at a whopping Rs 3.7 lakh; Software engineers, physicians, teachers, accountants, analysts, among others are the professionals  who saw the biggest loss of jobs among salaried employees due to coronavirus lockdown; Hyderabad-based Dr Reddy's Laboratories (Dr Reddy's) and Russia's sovereign wealth fund Russian Direct Investment Fund (RDIF) have joined hands to carry out clinical trials and distribution of 100 million doses of coronavirus vaccine Sputnik V in India. Watch this and more on News Blast.

Also Read: 33% Delhiites exposed to coronavirus, have Covid antibodies, reveals latest sero survey

Lots of companies approvals have stalled owing to warning letters. That has affected the introduction and growth of new products, he said.

Frequent USFDA inspections slow down Indian pharma exports: CII official

Nov 18, 2019

Prasad said there was a need for the government to focus on and invest more in primary healthcare

Dr Reddy's Laboratories share price rose up to 2.06% to the intraday high of Rs 3936.35 compared to the previous close of Rs 3,856 on BSE.

Dr Reddy's Laboratories share price gains over 2% on USFDA nod for migraine drug

May 07, 2020

Dr Reddy's Laboratories share price closed flat at Rs 3,822 on BSE

Dr Reddy's Laboratories share price has gained 19.49% during the last one year. The stock has risen 10.84% since the beginning of this year

Dr Reddy's Laboratories share price hits 52-week high despite Rs 570-crore loss in Q3

Jan 27, 2020

Share price of Dr Reddy's Laboratories rose up to 5.92% to Rs 3,207.40 compared to the previous close of Rs 3,028.05 on BSE

Dr Reddy's Q2 numbers disappoint, all eyes now on margin improvements

Nov 02, 2019

Dr Reddy's CFO Saumen Chakraborty attributed much of the challenges in the US market to price erosion and lower volumes

Dr Reddy's CEO G V Prasad said it has been a good year with a significant turnaround in the financial performance and steady progress on the quality front.

Dr Reddy's Q4 PAT up 44 per cent at Rs 434 crore

May 17, 2019

Revenue for the quarter under discussion was up by 14 per cent at Rs 4,016.60 crore against Rs 3,534.90 crore in the same quarter last fiscal, the city-based drug-maker said in a press release.

Dr Reddy's reports Q2 numbers today; key things to watch out for

Oct 26, 2018

The pharma major had posted a robust performance in the June quarter of FY19, largely aided by the launch in the US of gSuboxone, the generic version of the drug to deal opioid addiction.